PlainPharmaWatch

CMS Open Payments · Program Year 2024

Scientia Vascular

Scientia Vascular reported $46,916,063.81 across General Payments, Research, and Ownership to 191 physicians and teaching hospitals across 228 transactions.

$46.9M
All-tracks total
228
Transactions
191
Recipients
−$4.2K
General Payments vs PY2023

Scientia Vascular reported $46,916,063.81 across all CMS Open Payments tracks (General + Research + Ownership) to 191 physicians and teaching hospitals in Program Year 2024 - ranking #52 of 1,925 reporting manufacturers (0.3% of the all-tracks industry total); General Payments alone were $184,786.83, averaging $245.6K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer scientia-vascular Scientia Vascular

$46.9M · #52/1,925 · 0.3% industry · PY2024

  • TOT $46.9M
  • RANK #52
  • SHARE 0.3%
  • TXN 228
  • RCP 191
  • CAT 3
  • GEN $184.8K
  • ΔGEN −$4.2K
  • TOP1 33.1%
  • PY 2024

Nearest volume peer: Cleerly, Inc. ($47.5M)

Sumitomo Pharma America, Inc.$48.1MITI, Inc. (d/b/a Intra-Cellu…$47.9MCleerly, Inc.$47.5MScientia Vascular (this)$46.9MImperative Care, Inc$45.6M
All-tracks payment totals near Scientia Vascular (CMS Open Payments PY2024)

Scientia Vascular sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Scientia Vascular's CMS-reported General Payments decreased by $4.2K (−2.2%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: SCIENTIA VASCULARPY2023: SCIENTIA VASCULARPY2024: Scientia Vascular. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$189.0KPY2024$184.8K
PY2023
$189,027.67
PY2024
$184,786.83

What the Data Shows for Scientia Vascular

In Program Year 2024, Scientia Vascular reported $46,916,063.81 in payments to 191 physicians and teaching hospitals across 228 individual transactions, an average of $205.8K per transaction and $245.6K per recipient. That total places Scientia Vascular at rank #52 out of 1,925 companies in the CMS Open Payments database, representing 0.3% of all industry payments reported nationwide for the year.

Of the 3 general-payment categories charted below, "Consulting Fee" is the largest at $154.3K across 41 transactions, 83.5% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 3 types of general payments, Scientia Vascular's largest category was "Consulting Fee" at $154.3K - 83.5% of General Payments.

How Scientia Vascular divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$154.3K2. Food and Beverage$18.4K3. Travel and Lodging$12.0K
Payment Type Amount Transactions
Consulting Fee $154.3K 41
Food and Beverage $18.4K 129
Travel and Lodging $12.0K 21

Recipient Concentration in General Payments

The five largest recipient relationships account for $149,699.20 (81.0%) of $184,786.83 in this company's General Payments records across 59 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Scientia Vascular

The five named recipients with the highest reported General Payments from this company

Adam Arthur$61.1KDavid Fiorella$60.0KJohn Deveikis$19.8KDaniel Sahlein$4.8KHaris Kamal$4.0K
  1. 1

    Adam Arthur

    $61,118.00 across 13 reported transactions

  2. 2

    David Fiorella

    $60,000.00 across 12 reported transactions

  3. 3

    John Deveikis

    $19,755.42 across 14 reported transactions

  4. 4

    Daniel Sahlein

    $4,805.62 across 11 reported transactions

  5. 5

    Haris Kamal

    $4,020.16 across 9 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Scientia Vascular's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Scientia Vascular.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Scientia Vascular.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Scientia Vascular's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.